| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.9 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.0061 | 0.9 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.028 | 0.9 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |